MERTK and gastric cancer: Given that peritoneal cavity metastasis is one of the major factors affecting the prognosis of GC patients,30 MerTK inhibition would be of great value in GAC therapy, decreasing the number of anchorage‐independent cells and thereby reducing the probability of metastasis.